Stem Cell Therapy Market Size, Share, Industry Trends and Forecast to 2030

1. What is the Market Size & CAGR of Stem Cell Therapy market in 2021?

The global stem cell therapy market had a market size of USD 14.61 billion in 2021, with a Compound Annual Growth Rate (CAGR) of 8.2% from 2021 to 2028. The market is expected to reach USD 24.73 billion by 2028.

2. COVID-19 Impact on the Stem Cell Therapy Market

The outbreak of COVID-19 has had a significant impact on the stem cell therapy market. The pandemic led to disruptions in the healthcare sector, affecting the manufacturing and distribution of stem cell products. However, with the growing importance of regenerative medicine in treating COVID-19 patients, the market for stem cell therapy is expected to witness growth in the coming years.

3. Stem Cell Therapy Dynamics

Stem cell therapy offers a promising approach to treating a variety of diseases and injuries by harnessing the regenerative capabilities of stem cells. The therapy has shown remarkable potential in areas such as orthopedics, neurology, oncology, and cardiology. Advancements in technology and increasing research in stem cell biology are driving the growth of the stem cell therapy market.

4. Segments and Related Analysis

The stem cell therapy market is segmented based on cell source, type of therapy, application, and end-user. Mesenchymal stem cells (MSCs) hold a significant market share due to their versatility and effectiveness in various therapeutic applications. Regenerative medicine, cell-based immunotherapy, and cell-based gene therapy are some of the key therapy types driving market growth.

5. By Region Analysis

The stem cell therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has the largest market share, driven by advancements in healthcare infrastructure, favorable regulatory policies, and the presence of key market players. Asia Pacific is expected to witness significant growth due to growing investments in healthcare and biotechnology sectors.

6. Key Market Players and Competitive Landscape

Key players in the stem cell therapy market include Mesoblast Ltd, Vericel Corporation, Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co. Ltd, and NuVasive, Inc. These companies are focusing on research and development initiatives, strategic collaborations, and product portfolio expansion to gain a competitive edge in the market.

7. Recent happenings in the Stem Cell Therapy Market

In recent developments, Mesoblast Ltd announced positive results from a Phase 3 trial of its stem cell therapy for acute graft-versus-host disease. Vericel Corporation received FDA approval for its cell therapy product for treating cartilage defects in the knee. Holostem Terapie Avanzate Srl collaborated with a leading research institute to develop new stem cell therapies for skin regeneration.